News
Health plan trustees at a Minneapolis-based construction workers union are suing a subsidiary of UnitedHealth Group for ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...
The Financial Supervisory Service issued its latest consumer advisory pertaining to insurance claims for various forms of ...
7h
India Today on MSNUS employers to cut health benefits amid soaring weight-loss drug costs: SurveyOver half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...
44m
News-Medical.Net on MSNGLP-1 weight-loss drugs are reshaping modern dating and intimacyGLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad ...
If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...
SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...
The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results